Fox Run Management, L.L.C. Novartis Ag Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Novartis Ag stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 17,840 shares of NVS stock, worth $2.1 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
17,840
Previous 14,489
23.13%
Holding current value
$2.1 Million
Previous $1.41 Million
41.09%
% of portfolio
0.33%
Previous 0.27%
Shares
19 transactions
Others Institutions Holding NVS
# of Institutions
1,542Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$830 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$796 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...